Je was op zoek naar: transplantaciji (Kroatisch - Engels)

zapreke u transplantaciji organa odnose živote
hurdles in organ transplants cost lives

bolesnici koji su bili podvrgnuti transplantaciji koštane srži nakon kemoterapije:
patients having a bone marrow transplant after chemotherapy:

ako se podvrgavate transplantaciji bubrega, potrebno je prekinuti liječenje lijekom nutropinaq.
if you undergo a kidney transplant nutropinaq treatment should be stopped.

bolesnika koji će biti podvrgnuti transplantaciji jetre i kod novorođenčadi do 4 tjedna starosti.
patients in the perioperative liver transplantation period and in neonates up to 4 weeks of age.

vfend se također ispitivao kao preventivno liječenje u bolesnika koji su podvrgnuti transplantaciji matičnih stanica.
vfend has also been studied as a preventative treatment in patients who have had blood stem-cell transplantation.

zakon o transplantaciji u bosni i hercegovini dozvoljava da se postane donor organa potpisivanjem donorske kartice.
bosnia and herzegovina's (bih) organ transplant law allows one to become a donor after signing a donor card.

zalmoxis se mora primjenjivati pod nadzorom liječnika s iskustvom u transplantaciji hematopoetskih matičnih stanica zbog hematoloških zloćudnih bolesti.
zalmoxis must be administered under the supervision of a physician experienced in haematopoietic stem cell transplantation for haematological malignacies.

bolesnici profilaktički liječeni mikafunginom bili su oni na transplantaciji matičnih hematopoetskih stanica i u kojih je postojao visoki rizik od gljivičnih infekcija.
patients treated prophylactically with micafungin were those undergoing haematopoetic stem cell transplantation (hsct) who were at high risk for fungal infections.

kako nema dostupnih podataka o primjeni tafamidismeglumina nakon transplantacije jetre, primjenu tafamidismeglumina treba prekinuti u bolesnika koji se podvrgnu transplantaciji jetre.
as there are no data available regarding the use of tafamidis meglumine post-liver transplantation, tafamidis meglumine should be discontinued in patients who undergo liver transplantation.

kod bolesnika koji će biti podvrgnuti transplantaciji jetre i kod novorođenčadi do 4 tjedna starosti (vidjeti dio 4.4).
in patients in the perioperative liver transplantation period and in neonates up to 4 weeks of age (see section 4.4).

drugo je ispitivanje obuhvatilo 488 bolesnika s aml-om u dobi od 65 godina ili starijih koji se nisu mogli podvrgnuti transplantaciji hematopoetskih matičnih stanica.
the second study involved 488 patients with aml who were 65 years or older and could not have haematopoietic stem cell transplantation.

bolesnici kod kojih je transplantirana jetra, odnosno koji će biti podvrgnuti transplantaciji jetre su posebno ugroženi, budući da je u toj skupini visoka incidencija akutnog zatajenja bubrega.
patients who have had or are undergoing liver transplantation are at particular risk since the incidence of acute renal failure is high in this group.

bolesnici kod kojih je transplantirana jetra, odnosno koji će biti podvrgnuti transplantaciji jetre su posebno ugroženi, budući da je u toj skupini bolesnika visoka incidencija akutnog zatajenja bubrega.
patients who have had or are undergoing liver transplantation are at particular risk since the incidence of acute renal failure is high in this group.

u ovih se bolesnika lijek bortezomib sun koristi u kombinaciji s melfalanom i prednizonom; u bolesnika koji prethodno nisu liječeni i koji trebaju primiti kemoterapiju u visokim dozama te potom biti podvrgnuti transplantaciji hematopoetskih matičnih stanica.
in these patients, bortezomib sun is used in combination with melphalan and prednisone; previously untreated adults who are going to receive high-dose chemotherapy followed by blood stem-cell transplantation.

u tih bolesnika, lijek bortezomib hospira koristi se u kombinaciji s melfalanom i prednizonom; bolesnika koji nisu prethodno liječeni i koji trebaju primiti kemoterapiju u visokim dozama i potom biti podvrgnuti transplantaciji hematopoetskih matičnih stanica.
in these patients, bortezomib hospira is used in combination with melphalan and prednisone; previously untreated adults who are going to receive high-dose chemotherapy followed by blood stem-cell transplantation.

prvo je ispitivanje obuhvatilo 358 odraslih osoba s mijelodisplastičnim sindromima srednjeg do visokog rizika, cmml-om ili aml-om, za koje nije bilo izgledno da će se podvrgnuti transplantaciji matičnih stanica.
the first study involved 358 adults with intermediate to high-risk myelodysplastic syndromes, cmml or aml, who were unlikely to go on to have a stem cell transplant.

dodatna su ispitivanja pokazala da lijek sovaldi u kombinaciji s ribavirinom smanjuje rizik od infekcije presađene jetre virusom hepatitisa c u bolesnika koji su bili podvrgnuti transplantaciji, da je lijek sovaldi također djelotvoran u bolesnika koji su zaraženi i virusom hepatitisa c i hiv-om te da se ishod u bolesnika s infekcijom genotipom 3 može poboljšati ako se liječenje produži na 24 tjedna.
additional studies showed that sovaldi in combination with ribavirin decreased the risk of infection of the new liver with hepatitis c virus in patients undergoing transplantation, that sovaldi is also effective in patients infected with both hepatitis c and hiv, and that the outcome of patients with genotype 3 infection could be improved by extending treatment to 24 weeks.